819
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study

, , , , , , , , , , , & show all
Pages 503-513 | Received 02 Oct 2014, Accepted 18 Dec 2014, Published online: 11 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Moeko Ochiai, Eiichi Tanaka, Eri Sato, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Yoko Higuchi, Rei Yamaguchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2021) Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. Modern Rheumatology 31:4, pages 790-795.
Read now
Yoshiyuki Abe, Keigo Saeki, Hiroaki Dobashi, Tamihiro Kawakami, Taichi Hayashi, Masaki Kobayashi, Shinya Kaname, Masayoshi Harigai & Naoto Tamura. (2021) Clinical characteristics and social productivity levels of patients with malignant rheumatoid arthritis based on a nationwide clinical database in Japan: annual survey from 2003 to 2013. Modern Rheumatology 31:3, pages 621-628.
Read now
Yoko Shimizu, Eiichi Tanaka, Eisuke Inoue, Kumi Shidara, Naoki Sugimoto, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2018) Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. Modern Rheumatology 28:3, pages 461-467.
Read now
Jun Kikuchi, Tsuneo Kondo, Akiko Shibata, Ryota Sakai, Yusuke Okada, Kentaro Chino, Ayumi Okuyama, Takahiko Kurasawa, Hirofumi Takei & Koichi Amano. (2018) Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis. Modern Rheumatology 28:3, pages 444-451.
Read now
Eiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, Yoko Shimizu, Akiko Kobayashi, Naoki Sugimoto, Daisuke Hoshi, Kumi Shidara, Eri Sato, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2017) Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan. Modern Rheumatology 27:2, pages 227-236.
Read now
Hideki Nakamura, Naoki Iwamoto, Takehiro Matsumoto & Atsushi Kawakami. (2016) An effective medical partnership in Nagasaki, Japan for patients with rheumatoid arthritis. Modern Rheumatology 26:6, pages 878-884.
Read now

Articles from other publishers (9)

Hisashi Yamanaka, Mitsumasa Kishimoto, Nobuo Nishijima, Katsuhisa Yamashita, Junnosuke Matsushima, Jacqueline O’Brien, Taylor Blachley, Melissa Eliot, Zachary Margolin, Swapna S Dave & Yoshiya Tanaka. (2023) Socioeconomic impact of treatment with biological disease–modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis. Modern Rheumatology.
Crossref
Eiichi Tanaka, Eisuke Inoue, Ayako Shoji, Jonas Nilsson, Christos Papagiannopoulos, Devender Dhanda, Yuri Yoshizawa, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLOS ONE 17:11, pages e0277566.
Crossref
Li Jiao & Shougang Guo. (2022) Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases. Frontiers in Immunology 13.
Crossref
Keisuke Izumi, Okinori Murata, Misako Higashida-Konishi, Yuko Kaneko, Hisaji Oshima & Tsutomu Takeuchi. (2021) Steroid-Sparing Effect of Tocilizumab and Methotrexate in Patients with Polymyalgia Rheumatica: A Retrospective Cohort Study. Journal of Clinical Medicine 10:13, pages 2948.
Crossref
Kristen L. Nowak, Rahul Kakkar, Matt Devalaraja, Larry Lo, Wansu Park, Joga Gobburu, Douglas Kling, Michael Davidson & Michel Chonchol. (2021) A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD. Kidney360 2:2, pages 224-235.
Crossref
Yentel Mateo-Otero, José María Sánchez, Sandra Recuero, Sandra Bagés-Arnal, Michael McDonald, David A. Kenny, Marc Yeste, Pat Lonergan & Beatriz Fernandez-Fuertes. (2020) Effect of Exposure to Seminal Plasma Through Natural Mating in Cattle on Conceptus Length and Gene Expression. Frontiers in Cell and Developmental Biology 8.
Crossref
Salah Ghabri, Laurent Lam, François Bocquet & Hans-Martin Spath. (2020) Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs. PharmacoEconomics 38:5, pages 459-471.
Crossref
Evo Alemao, Maiwenn J. Al, Annelies A. Boonen, Matthew D. Stevenson, Suzanne M. M. Verstappen, Kaleb Michaud, Michael E. Weinblatt & Maureen P. M. H. Rutten-van Mölken. (2018) Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis. PLOS ONE 13:10, pages e0205013.
Crossref
Ya-Qun Zhou, Zheng Liu, Zhi-Heng Liu, Shu-Ping Chen, Man Li, Allahverdi Shahveranov, Da-Wei Ye & Yu-Ke Tian. (2016) Interleukin-6: an emerging regulator of pathological pain. Journal of Neuroinflammation 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.